Compare CDNA & AVAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDNA | AVAH |
|---|---|---|
| Founded | 1998 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.4B |
| IPO Year | 2007 | 2021 |
| Metric | CDNA | AVAH |
|---|---|---|
| Price | $22.86 | $7.22 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 9 |
| Target Price | ★ $28.00 | $9.75 |
| AVG Volume (30 Days) | 583.8K | ★ 1.5M |
| Earning Date | 04-28-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1850.00 |
| EPS | 0.05 | ★ 0.19 |
| Revenue | $48,324,000.00 | ★ $2,433,199,000.00 |
| Revenue This Year | $16.01 | $7.31 |
| Revenue Next Year | $11.31 | $5.59 |
| P/E Ratio | $455.40 | ★ $38.71 |
| Revenue Growth | 18.93 | ★ 20.19 |
| 52 Week Low | $10.96 | $3.73 |
| 52 Week High | $23.24 | $10.32 |
| Indicator | CDNA | AVAH |
|---|---|---|
| Relative Strength Index (RSI) | 65.92 | 51.30 |
| Support Level | $15.80 | $6.18 |
| Resistance Level | $22.89 | $7.52 |
| Average True Range (ATR) | 0.95 | 0.35 |
| MACD | 0.11 | -0.02 |
| Stochastic Oscillator | 90.52 | 41.95 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). The Private Duty Services segment generates the majority of revenue, which includes private duty skilled nursing services, non-clinical and personal care services, and pediatric therapy services, and is principally reimbursed by Medicaid and Medicaid MCO.